The hepatitis B virus protein HBx is a promiscuous transactivator implicated in both cell growth and death and in the development of hepatocellular carcinoma. We recently reported that HBx can potentiate c-myc-induced liver oncogenesis in a transgenic model where low level expression of HBx induces no pathology. To assess if HBx could aect the hepatocyte turnover, we investigated the HBx-elicited apoptotic responses in transgenic livers and in primary hepatocyte cultures. Here we show that transgenic expression of HBx is associated with a twofold increase of spontaneous cell death in the mouse liver. The ®nding that apoptosis was enhanced to similar extents in HBx mice carrying homozygous p53 null mutations implied that functionally intact p53 was not required to transduce the death signal. A direct, dosedependent apoptotic function of HBx was demonstrated in transient transfections of liver-derived cell lines. We further show that stable expression of HBx at low, presumably physiological levels in primary hepatocytes, induced cellular susceptibility to diverse apoptotic insults, including growth factor deprivation, treatment with antiFas antibodies or doxorubicine and oxidative stress. HBx expression, but not p53 status profoundly aected the commitment of cells to die upon apoptotic stimuli. These data strengthen the notion that HBX may contribute to HBV pathogenesis by enhancing apoptotic death in the chronically infected liver.
Introduction
The human hepatitis B virus (HBV) is a small, hepatotropic DNA virus responsible for acute and chronic liver disease worldwide. Despite epidemiological evidence linking chronic HBV infection and the development of hepatocellular carcinoma (Beasley et al., 1981) , the mechanisms of HBV-induced carcinogenesis remain obscure. The long latency period of tumor development strongly argues against acute oncogenic eects of HBV. Integration of HBV DNA into the host genome has been detected in most HBVassociated HCCs, but reported cases of direct insertional activation of cellular genes remain extremely rare (Dejean et al., 1986; Wang et al., 1990) . It has been proposed that chronic liver damage and compensatory regeneration induced by the host immune response and by long-term expression of viral genes might favor the accumulation of genetic defects (Chisari et al., 1989) . The HBV-encoded regulatory protein HBx, also known as the HBx antigen (HBxAg) or pX, might be a prime candidate for mediating HBV pathological eects. The X gene is conserved among tumorigenic mammalian hepadnaviruses, and it is required for virus replication in the woodchuck host (Chen et al., 1993; Zoulim et al., 1994) . The 16.5 kDa HBx protein is a multifunctional transactivator which up-regulates a variety of viral and cellular genes through protein ± protein interactions. In the nucleus, HBx may function as a co-activator by interacting with elements of the transcription machinery (Cheong et al., 1995; Haviv et al., 1998; Qadri et al., 1995) , and from cytoplasmic locations by activating Ras/Raf signaling and NF-kB (Benn and Schneider, 1994; Cross et al., 1993; Natoli et al., 1994; Su and Schneider, 1996) .
In the absence of indisputable experimental evidence for a dominant oncogenic activity of HBx, several lines of studies support the contribution of the viral transactivator to liver oncogenesis. Transgenic expression of the X gene has been shown to induce frequent liver tumors in a transgenic mouse line generated in the CD1 background (Kim et al., 1991) . In other murine lines, HBx induced no pathology, but it sensitized liver cells to the carcinogenic eects of diethylnitrosamine (Dandri et al., 1996; Slagle et al., 1996) , and cooperated with c-myc by accelerating the onset of liver tumors (Terradillos et al., 1997) . In human HBV carriers, HBx expression is preferentially maintained through the multistage process from preneoplastic nodules to HCC and peritumoral tissues (Su et al., 1998) and X-speci®c mRNAs selectively accumulate in liver tumors from HBsAg-negative patients (Paterlini et al., 1995) . Relevant to how HBx might participate in cell transformation, the X gene product stimulates cell cycle progression, DNA synthesis and apoptosis (Benn and Schneider, 1995; Chirillo et al., 1997; Su and Schneider, 1997) . There is also evidence to indicate that HBx may bind a variety of cellular target genes (Fischer et al., 1995; Lee et al., 1995; Sirma et al., 1998) , and notably the tumor suppressor protein p53 (Feitelson et al., 1993; Lin et al., 1997; Ueda et al., 1995) . HBx was shown to sequester the p53 protein in the cytoplasm and to inactivate its transactivating and apoptotic properties (Elmore et al., 1997; Takada et al., 1997; Truant et al., 1995; Wang et al., 1994 Wang et al., , 1995 . In other reports however, inhibition of known cellular functions of p53 could not be evidenced in cells with replicative HBV (Puisieux et al., 1995) , and the apoptotic activity of the X gene product was found to require wild-type p53 (Chirillo et al., 1997) .
In this paper, we investigated the apoptotic activity of the X protein in dierent conditions in vivo and in vitro. Using a genetic approach, we show that transgenic expression of HBx is associated with increased spontaneous apoptosis in mouse liver in situ and with enhanced sensitivity of hepatocyte cultures to a variety of apoptotic stimuli, in a manner that does not require expression of the p53 gene. Evidence that forced overexpression of HBx induces apoptotic death in transiently transfected cells indicates that the HBV transactivator protein is endowed with intrinsic proapoptotic properties.
Results

p53-independent increase of liver cell apoptosis in HBx transgenic mice
HBx transgenic mice from AX16 and PEX7 lines produce weak amounts of the HBx protein in the neonatal liver (Terradillos et al., 1997) . X-speci®c transcripts and HBx protein declined with age and fell to undetectable levels in adult livers. In both lines, HBx transgene expression by itself induced no liver neoplasm, but it co-operated with a c-myc transgene by accelerating the onset of primary liver tumors (Terradillos et al., 1997) . These data prompted us to investigate the ability of HBx to alter the hepatocyte turnover.
Hepatocyte proliferation and apoptosis were measured in liver tissues from 15-day-old animals by counting BrdU-and TUNEL-positive hepatocytes. As shown in Table 1 , the fraction of S phase, BrdUlabeled hepatocytes was comparable in transgenic and non-transgenic mice. In contrast, a twofold increase of apoptotic hepatocytes was observed in transgenic livers compared to age-matched controls. Figure 1a shows a representative example of a TUNEL-positive cell scored as apoptotic on the basis of condensed chromatin and fragmented nuclei. In control experiments, TUNEL-positive hepatocytes showed identical morphological patterns in mice injected with anti-Fas antibodies, in which a dose-dependent, 5 ± 15-fold increase of apoptotic cell counts was evidenced 4 h after injection (Figure 1c and d) . The apoptotic rate returned to normal in adult animals from both strains, which may well correlate with almost complete loss of X gene expression (data not shown).
Because previous reports had described physical interactions between HBx and p53 proteins that could aect apoptotic processes (Ueda et al., 1995; Wang et al., 1995) , we evaluated the eect of the p53-null genotype on liver cell apoptosis in HBx-expressing animals. Hybrid mice (HBx/p53 +/7 and HBx/p53 7/7 ) were generated by crossing PEX7 and AX16 transgenics with p53-null mice (Jacks et al., 1994) . In Northern blot analysis of liver RNA from transgenic mice at dierent ages, HBx expression was not aected by the p53 status (Figure 2 ). Hepatocyte apoptosis was examined by TUNEL in 15-day-old p53 7/7 and HBx/ p53 7/7 animals. As shown in Table 1 , the basal apoptotic rates were similar in normal and p53-null livers, while apoptosis was increased by twofold in transgenic livers on p53 +/7 and p53 7/7 backgrounds. Thus in this model, HBx expressed at low levels was reproducibly associated with a moderate increase of liver cells apoptosis, independently of p53 status.
HBx expression sensitizes immortalized hepatocytes to dierent apoptotic stimuli
To assess if increased cell death in the transgenic liver re¯ected an intrinsic pro-apoptotic activity of HBx, we investigated the eect of constitutive expression of the X gene in hepatocyte cultures derived from X transgenic mice. Primary hepatocytes were isolated from p53-null and HBx/p53-null mice, giving rise to spontaneously immortalized cells called MHP53N and MHXP53N, which failed to grow in soft agar and retained an hepatocyte-like morphology (TP, manuscript in preparation). In parallel, we studied two other hepatocyte cell lines: MMHD3, established from a ATcyto-MET transgenic mouse, which express a truncated form of c-Met and are known to be resistant to dierent apoptotic stimuli (Amicone et al., 1997) and X-Met cells derived from the liver or a HBx/AT-cyto-MET bitransgenic animal (MT, unpublished data). Both these cell lines display a phenotype of well dierentiated hepatocytes, and they produce high levels of p53 mRNA as shown by Northern blot analysis ( Figure 3 ). Comparative analysis of X gene expression in MHXP53N and X-Met cells and in the transgenic liver in situ showed that X mRNA levels were similar in MHXP53N and X-Met cells, but lower than in liver of 15-day-old transgenic mice (Figure 3 ) and the HBx protein remained below the threshold of detection in both cell lines by Western blotting and immunocytochemistry (data not shown). Similar data were obtained in cell cultures at early and late passages, and in dierent subclones isolated from freshly explanted HBx/p53-null hepatocytes (data not shown).
Apoptosis was induced in the four cell lines by incubation for 24 h with either doxuribicin or anti-Fas antibodies at dierent concentrations, or in serum and growth factor-free medium. Cell viability was quantitated 24 h later by the MTT assay. In parallel experiments, cellular exposure to hydrogen peroxyde, a representative reactive oxygen species (ROS), was for 0.5 ± 6 h. Most MHP53N and MMHD3 cells remained viable after doxorubicin, Jo2 and hydrogen peroxyde treatments, while X-expressing cells from the MHXP53N and X-Met lines showed a sharp decline in the capacity to metabolize MTT (Figure 4) . Similarly, growth factor deprivation had little eect on the viability of MHP53N and MMHD3 cells, with 70 ± 80% survival at 48 h, but only 21% and 48% of X-expressing cells survived in X-Met and MHXP53N lines (data not shown). As illustrated in Figure 5 for doxuribicin-treated cells, most MHP53N and MMHD3 cells retained a normal morphology, but MHXP53N and X-Met cells exhibited massive cell death, manifested by cell shrinkage, membrane blebbing and loss of cell-cell contact. Apoptotic death was demonstrated in X-expressing cells after growth factor withdrawal or exposure to doxorubicin by staining with 7-AAD, an intercalating DNA dye which permits discrimination between viable and dying cells based on alterations of membrane integrity during apoptosis (Schmid et al., 1994) , and quantitative¯ow cytometry analysis (results not shown). Thus, constitutive expression of HBx at low levels had no direct apoptotic activity, but it sensitized immortalized hepatocytes to dierent apoptotic stimuli, independently of p53 expression.
Transient overexpression of HBx induces apoptosis
As HBx required additional death stimulus to promote apoptosis when stably expressed at low levels in cell cultures, we next asked whether transient overexpression of HBx was sucient to induce apoptosis. HepG2 and MMHD3 cells were transfected with either dierent amounts of pCMV-HBx or 3 mg of the proapoptotic FADD gene cDNA vector or the empty vector pcDNA3, together with the pCH110 bgalactosidase vector. After 48 h, cells were ®xed and stained with X-gal. Currently, about 10% of HepG2 and 40 ± 50% of MMHD3 cells scored positive for bgalactosidase. After transfection with pCMV-HBx, a proportion of blue cells displayed condensed morphology and dark staining typical of apoptotic cells ( Figure  6 ), similar to FADD-expressing cells (data not shown). After transfection of MMHD3 cells with dierent amounts of pCMV-HBx, the percentage of apoptotic cells among blue cells varied in a dose-dependent manner ( Figure 6 ) and similar results were obtained after transfection of HepG2 cells (data not shown). However, in these conditions, the appearance of apoptotic features was less complete in X than in FADD-induced cell death. MMHD3 cells transfected Figure 3 Analysis of HBx and p53 expression in hepatocyte cell lines and in transgenic mouse liver. Total RNA from a 15-day-old (NB) and a 80-day-old (A) PEX7 transgenic mouse livers, and from the hepatocyte cell lines MMHD3, X-Met, MHP53N and MHXP53N was probed with the X coding region (Upper), p53 cDNA (Middle) and ribosomal 18S cDNA (Lower). p53wt denotes normal sized p53 transcripts. The p53D mutation in the two cell lines derived from p53-null mice (Jacks et al., 1994) results in mRNAs of shorter size with various amounts of pCMV-WHx also showed dose-dependent increase in apoptotic rates (Figure 6 ), indicating that the regulatory protein of WHV shares pro-apoptotic activity with its human homologue. Typical morphological alterations in X-induced apoptosis were accompanied by chromatin condensation and DNA fragmentation revealed by TUNEL staining (data not shown).
We then devised a quantitative, two-color¯ow cytometry assay to directly evaluate apoptosis in the transfected cell population. MMHD3 cells were cotransfected with expression vectors for HBx and H2Kd, which served as a marker at the membrane of transfected cells. The detection of HBx in H2Kd-positive cells is shown in Figure 7 by the simultaneous staining for HBx (red) and H2Kd (green) in cells harvested 24 h following transfection. The transiently expressed HBx protein was mainly detected in cell cytoplasm, reaching levels that greatly exceeded those of the transgenic liver and stable hepatocyte cell lines. For¯ow cytometry analysis, cells were stained with 7-AAD at 48 h after transfection, immediately harvested and stained with FITC-conjugated anti-H2Kd antibodies. Transfection with dierent amounts of pCMVHBx yielded a dose-dependent increase of apoptotic cells in the H2Kd-transfected compartment, ranging from 7 ± 10-fold compared to cells transfected with the empty vector (Figure 7c) . In comparing this method with our previous study (see Figure 6 ), the estimates of the apoptotic cell fraction agreed within 10%, thus validating the use of the two-color immuno¯uorescence assay. We also found that the apoptotic fraction was signi®cantly higher in FADD-expressing than in HBxexpressing cells when tested at 48 h post-transfection (Figure 7c ), suggesting that HBx was less ecient or required a longer delay than FADD in promoting cell death. Flow cytometry assays at 72 h after transfection with pCMV-HBx demonstrated a complete, advanced stage of apoptosis (data not shown). Together these data demonstrate that HBx is endowed with intrinsic pro-apoptotic activity.
Discussion
In this study, the ability of HBx to activate an apoptotic pathway was demonstrated in dierent systems in vivo and in vitro. In X transgenic mice, we reported previously that HBx expression was detectable at the protein level in the neonatal liver, but not in Figure 4 Dierential sensitivity of X-expressing and nonexpressing hepatocytes to various apoptotic stimuli. (a) Fas killing was triggered by the addition of anti-Fas (Jo2) antibodies at dierent concentrations. (b) Cells were exposed for 24 h to doxorubicine at dierent doses, then the medium was renewed and cells were examined 24 h later. (c) Cells were exposed to 200 mM H 2 O 2 for the indicated periods of time. Cell survival was quantitated by colorimetric MTT assay which measures the mitochondrial activity in viable cells adults in which the X gene is strongly downregulated (Terradillos et al., 1997) . Here we show increased rates of spontaneous apoptosis in the livers of these transgenic neonates. We further show that low level expression of HBx sensitizes transgenic hepatocyte cultures to a variety of apoptotic stimuli while forced overexpression of HBx triggers apoptotic death in transfected cells. These data imply that the concentration of HBx protein and the cellular context play important roles in the decision as to whether a cell will respond to HBx by executing an apoptotic program. In the liver context of HBV-infected patients, it remains unknown whether the amounts of HBx present naturally may be sucient to trigger apoptosis. However, the HBx protein is hardly detectable in HBV infections, and low levels of the X gene product (Dandri et al., 1996; Wang et al., 1991) . Furthermore, recent immunohistological studies of human livers with HBV infection, using a panel of monoclonal and polyclonal anti-X antibodies, have detected a moderate HBx-speci®c reactivity only in a small number of hepatocytes (Su et al., 1998) . Hence, the cellular response to physiological levels of HBx should conceivably result in increased sensitivity to apoptotic insults rather than direct apoptotic suicide, as proposed in a recent report demonstrating that HBx sensitizes cells to apoptotic killing by tumor necrosis factor a (TNFa) (Su and Schneider 1997) .
Because the p53 tumor suppressor protein is involved in cell death control in a wide array of biological systems, and physical interactions of HBx with p53 might modulate apoptotic responses, we examined the requirement for p53 in HBx apoptotic activity. Here we show that HBx retains apparently unaltered apoptotic function in liver cells lacking a functional p53 gene, both in vivo and in vitro. These data, as well as the observation that HBx induces apoptosis in transient transfections of HeLa cells, in which the p53 protein is degraded through the action of the HPV E6 protein, argue that p53-independent pathways underlie the toxic action of HBx. There are other similar examples among viral oncoproteins and cellular oncogenes involved in cell death regulation. The adenovirus E1A, HTLV-1 Tax and human papilloma virus (HPV) E7 proteins stimulate cell proliferation and also cause apoptosis, by both p53-dependent and p53-independent mechanisms (Debbas and White, 1993); Pan and Griep, 1995; Teodoro et al., 1995; Yamada et al., 1994) and the transcriptional regulator E2 of HPV can trigger apoptosis independently of p53 transcriptional activity (Desaintes et al., 1997) . Overexpression of c-myc can lead to apoptosis that requires a property intrinsic to p53 in serumstarved ®broblasts, but it may operate through p53-independent pathways in epithelial cells, or during lymphomagenesis (Hsu et al., 1995; Sakamuro et al., 1995; Wagner et al., 1994) . Providing an additional degree of complexity, there are dierent ways by which wild-type p53 can modulate cell suicide responses: it may exert a protective eect by inducing cell cycle arrest, or induce apoptosis through transcriptionally dependent and independent mechanisms (Haupt et al., 1995) . Thus, cell-type speci®cities might account for the discrepancy between our results and the reported requirement for p53 in mediating HBx-induced cell death in NIH3T3 cells (Chirillo et al., 1997) . The interaction of HBx with p53 and the contrasting ability of HBx to block p53-induced apoptosis (Elmore et al., 1997; Wang et al., 1995) were not addressed in this study.
Evidence that HBx expression is detrimental to cell viability was provided in earlier studies by the diculty in generating stable cell clones that express the X protein (Kim et al., 1998; Oguey et al., 1996) . We succeeded in establishing permanent cell lines which stably expressed HBx by isolating hepatocytes from HBx/p53-null and HBx/AT-cyto-MET bitransgenic animals. Importantly, HBx was able to overcome the known resistance to apoptotic death conferred to cells by p53 de®ciency, or by association of activated c-Met with the anti-apoptotic protein BAG-1 (Amicone et al., 1997; Bardelli et al., 1996; Hooper, 1994) . The observation that HBx-expressing cells were equally sensitive to apoptotic signals provided by a DNAdamaging agent and by oxidative stress may be relevant to hepadnavirus pathogenesis, as recent studies have shown that the oxidative burst associated with viral infections leads to DNA damage through increased production of toxic oxygen radicals (Peterhans, 1997; Petersen et al., 1997) . Conversely, mitogenic growth factors were necessary to mitigate the underlying apoptotic program implemented by HBx, corroborating previous report that IGF-II blocks TNFa-induced apoptosis in HBx-expressing cells (Su and Schneider, 1997) . However, information on the cellular eectors which mediate HBx-induced apoptosis remains so far limited, although caspase activation has been implicated at the ®nal execution stage (Chirillo et al., 1997; TP, unpublished observations) . In this regard, our data showing delayed appearance of apoptotic features in HBx compared to FADD-induced apoptosis indicates that more steps may be required at early stages of the apoptotic pathway triggered by HBx. Interestingly, the X gene product was shown to function as a cytoplasmic activator of Src family kinases for induction of downstream Ras signaling, which is consistent with HBx's activity in stimulating transcription from the cmyc and N-myc promoters (Klein and , and the c-myc and N-myc genes have been involved in HBx-mediated apoptosis (Chirillo et al., 1997; Su and Schneider, 1997) . Evidence that HBx's activities in transcriptional activation and in apoptosis might be coupled (C BreÂ chot, personal communication; TP, unpublished data) lends further support to this hypothesis. It is therefore possible that HBx induces cell death by activating myc genes and downstream mediators of the myc apoptotic signal. Whether alterations in mitochondrial structure and function are associated with early or late steps of HBx-induced cell death, and whether biologically relevant apoptosismodulating proteins of the Bcl-2 family play a regulatory role during this process are also important questions.
Apoptosis may be one of the primary antiviral defense mechanisms of the infected cell, and many animal viruses encode one or more protein(s) which interact with cell death regulatory pathways. Antiapoptotic stratgegies may be bene®cial for viruses to establish persistent infections, but for less obvious reasons, a number of non-lytic viruses, including HIV, HTLV-1, HPV and HBV have developed pro-apoptotic functions (Desaintes et al., 1997; Westendorp et al., 1995; Yamada et al., 1994) . It has been proposed that apoptosis could represent an important step by which such viruses disseminate progeny, by enhancing virus release and spread to new host cells (Teodoro and Branton, 1997) . Moreover, immunosuppressive eects of apoptotic cells leading to impaired cell-mediated immunity could allow the virus to evade host in¯ammatory responses, and protect the progeny virions (Voll et al., 1997) . During the multistep process of liver tumorigenesis, continuous cell killing and subsequent liver regeneration might favor the selection of cells that could develop survival strategies, as exempli®ed by the frequent reactivation of Igf-2 in liver tumors. Given that expression of HBx is generally maintained through all stages of the tumorigenic process and in HCCs (Su et al., 1988) , it might be important for the outgrowth of overtly transformed cell to counteract the proapoptotic activity of HBx. This notion is supported by the recent ®nding of mutations in the X open reading that abrogate HBx's functions as a transcriptional transactivator and cell death inducer in HBV-related HCCs (C BreÂ chot, personal communication). Detailed characterization of HBx-mediated apoptosis in physiological settings may provide new insights into the mechanisms of HBV persistence and pathogenesis and the contribution of the X regulatory protein in liver oncogenesis.
Materials and methods
Animals
The generation of AX16 and PEX7 transgenic mice has been described previously (Balsano et al., 1993; Billet et al., 1995) . Animals were crossed with inbred C57B1/6 mice to maintain the lines. The p53-null mice were derived from homologous recombination and crossed onto a C57B1/6 background (Jacks et al., 1994) . AX16 and PEX7 transgenic lines were bred with p53-null mice, and animals heterozygous for both the p53-null gene and the HBx transgene were subsequently backcrossed onto p53-null mice or bred together to generate transgenic mice on a p53 7/7 , p53 +/7 and p53 +/+ background.
In situ detection of apoptosis
Liver tissues were ®xed in 4% paraformaldehyde (PFA) and embedded in paran. Liver cells undergoing apoptosis were labeled by in situ nick-end labeling of nucleosomal DNA (TUNEL) as described previously (Terradillos et al., 1997) . Brie¯y, fragmented DNA was end-labeled with biotinylated-dUTP by terminal deoxynucleotide transferase and detected with ExtrAvidin-TRITC conjugate (Sigma). Tissues were counterstained with acqueous hematoxylin. Apoptotic hepatocytes were quanti®ed by counting 150 cells in each of 20 consecutive optic ®elds. The percentage of cells in S phase was quanti®ed by bromodeoxyuridine (BrdU) labeling as previously described (Terradillos et al., 1997) . Between-group comparisons were performed with the non-parametric Mann ± Whitney tests. Probability levels less than 0.05 were considered signi®cant (P50.05).
Cell lines
Hepatocytes were isolated from adult p53-null and transgenic HBx/p53-null mice by a two-step collagenase procedure described previously (Seglen, 1976) . The explanted liver cells were grown on collagen-coated dishes in DMEM/Ham's F12 medium supplemented with 10% fetal calf serum (FCS), 50 ng/ml EGF, a mixture of insulin, transferrin, and selenium (ITS; SIGMA), and 0.1 mM dexamethasone. Two permanent cell lines were established: MHP53N (p53-null) and MHXP53N (HBx/p53-null). Details of the murine hepatocyte cell line MMHD3 derived from the liver of a 3-day-old AT-cyto-MET transgenic mouse have already been reported (Amicone et al., 1997) . The X-Met hepatocyte cell line was derived from bitransgenic HBx/AT-cyto-MET embryonic liver at 18 days of gestation (MT, unpublished data). MMHD3 and X-Met lines were grown in RPMI supplemented with 10% FCS, 50 ng/ml EGF and 10 mg/ml insulin. Human hepatoma cells HepG2 were cultured in DMEM supplemented with 10% FCS.
RNA analysis
Total RNA was prepared from cell lines and liver tissues by a guanidinium isothiocyanate/phenol method (RNA PLUS, Bioprobe). RNA samples (30 mg per lane) were analysed by Northern blotting as described previously (Terradillos et al., 1997) . Blots were hybridized with the following probes: a 420 bp fragment of the HBVX gene, p53 cDNA (Soussi et al., 1988) , and a 0.2 kb PstI cDNA fragment of the murine 18S rRNA gene (Valbiotech).
Expression vectors
The X coding region of HBVayw was ampli®ed by PCR and the resulting 475 bp fragment (positions 1372 ± 1846 on the HBV map) was cloned into pcDNA3 (Invitrogen), which generated pCMV-HBx. X coding sequences of WHV (positions 1499 ± 1978 on the WHV8 map) were similarly cloned to construct pCMV-WHx. Coding regions were veri®ed by sequencing. The human FADD cDNA vector pcDNA3-AU1-FADD (Chinnaiyan et al., 1995) was provided by V Dixit. The plasmid pKC.Kd.wt (pH2Kd) containing the MHC class I H2Kd cDNA controlled by the SV40 early promoter was a gift from F Thierry.
MTT assay
Cells were grown in 96-well plates and incubated for 24 h with anti-mouse Fas antibodies (Jo2, PharMingen) or doxorubicin (Pharmacia) at the indicated concentrations, or deprived of serum and growth factors. One day later, MTT assays were performed as previously described (Sladowski et al., 1993) . For analysis of the response to oxidative stress, cells were exposed to 200 mM H 2 O 2 (Sigma) for 0.5 ± 6 h as described (Yakes and Van Houten, 1997) and immediately analysed. All treatments were tested in triplicate. Reduced MTT was solubilized with DMSO and the absorbance at 570 and 690 nm was measured.
Transfection, immunostaining and cell death assay For cell death assays, cells were transfected by calcium phosphate precipitation at 30% con¯uency in 6-cm dishes, using 1 mg of pCH110 and either 25 ng ± 20 mg of pCMVHBx or pCMV-WHx or 3 mg of pcDNA3-AU1-FADD (pFADD) and pcDNA3 was used to maintain a constant amount of DNA in each sample. Cells were ®xed 48 h later, stained with X-Gal as described (Chinnaiyan et al., 1995) , and visualized by phase-contrast microscopy. For each sample, 500 b-galactosidase-positive cells were counted. The data (mean+s.e.m.) from three experiments are expressed as the percentage of apoptotic blue cells among the total number of blue cells.
Flow cytometry
Two days after transfection, cells were incubated in PBS BSA azide containing 20 mg/ml 7-aminoactinomycin D (7-AAD; Sigma) for 30 min at 48C in the dark. Adherent and oating cells were harvested, incubated with FITCconjugated anti-H2Kd monoclonal antibodies in the presence of 20 mg/ml non¯uorescent actinomycin D, fixed in 1% PFA and analysed in a FACScan (Becton Dickinson)¯ow cytometer (Lecoeur et al., 1997) . Data from 10 000 events were registrated in logarithmic scale and analysed using the Cell Quest 2 software (BDIS).
